Abbott Laboratories CDR (ABL0)

Profile

https://www.abbott.com

Abbott Laboratories CDR is a Canadian Depositary Receipt providing investors with exposure to Abbott Laboratories, a global leader in healthcare product discovery, development, manufacturing, and sales. The company operates across four key segments: Established Pharmaceutical Products, offering branded generics for conditions like pancreatic exocrine insufficiency, hypertension, and hypothyroidism primarily in emerging markets; Diagnostic Products, including immunoassay, clinical chemistry, molecular diagnostics, and point-of-care testing systems; Nutritional Products, encompassing pediatric and adult formulas such as infant nutrition and adult shakes; and Medical Devices, featuring cardiovascular solutions like rhythm management, electrophysiology, and structural heart devices, alongside diabetes care with continuous glucose monitors and neuromodulation for chronic pain. Headquartered in Abbott Park, Illinois, and founded in 1888, Abbott Laboratories employs approximately 114,000 people worldwide, generating substantial revenue from diverse healthcare sectors including diagnostics, nutrition, and innovative medical technologies, underscoring its pivotal role in advancing global health solutions.